MedPath

Effects of Kampo medicines on the prevention of COVID-19

Not Applicable
Conditions
Coronavirus disease 2019
Registration Number
JPRN-UMIN000048389
Lead Sponsor
Department of Internal Medicine, Sapporo Suzuki Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Not provided

Exclusion Criteria

Someone which has a history of side effects to Kampo medicines

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
onset after exposure to infection
Secondary Outcome Measures
NameTimeMethod
Worsening after onset of infection
© Copyright 2025. All Rights Reserved by MedPath